Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Asia-Pacific Respiratory Monitoring Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Product Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Asia-Pacific Respiratory Monitoring Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Product Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Product Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Asia-Pacific Respiratory Monitoring Market, By Device Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Spirometers
      2. Peak Flow Meters
      3. Sleep Test Devices
      4. Gas Analyzers
      5. Pulse Oximeters
      6. Capnography

• 8.   Asia-Pacific Respiratory Monitoring Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Asthma
      2. COVID-19
      3. Others

• 9.   Asia-Pacific Respiratory Monitoring Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Hospitals
      2. Homecare
      3. Others

• 10.   Asia Pacific Respiratory Monitoring Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 11.   Market Share Analysis and Competitive Landscape
  •   1. Asia Pacific Landscape - Key Players, Revenue and Presence
      2. Asia Pacific Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Asia Pacific Emerging Companies
      4. Asia Pacific - Market Share Analysis and Key Regional Players
      5. Asia Pacific Key Player - Growth Matrix
    
• 12.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. Medtronic PLC
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Dragerwerk AGCo. KGaA
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. GE Healthcare
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Getinge AB
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Koninklijke Philips N.V
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Resmed
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Siemens Healthineers AG
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Teijin Pharma
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview

• 13.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                 administrations
      5. The overall economic slowdown of the developing and developed nations

• 14.   FutureWise SME Key Takeaway Points for Client